Biovie Inc Stock Investor Sentiment

BIVI Stock  USD 1.93  0.07  3.50%   
Under 74% of Biovie's investor base is looking to short. The analysis of the overall investor sentiment regarding Biovie Inc suggests that many traders are alarmed. Biovie's investing sentiment shows overall attitude of investors towards Biovie Inc.
  

Biovie Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Biovie can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over a week ago at newswire.com         
BioVie Inc. Joins Forces With New to The Street for a Dynamic 6-Part Media Campaign Featuring Long-F...
news
over a week ago at finance.yahoo.com         
BioVie Inc. Joins Forces With New to The Street for a Dynamic 6-Part Media Campaign Featuring Long-F...
Yahoo News
over two weeks ago at gurufocus.com         
BIOVIE ALERT Bragar Eagel Squire, P.C. is Investigating BioVie Inc. ...
Gurufocus Stories at Macroaxis
over three weeks ago at news.google.com         
BioVie Leaders Sued for Stock Slips on Clinical Trial Misconduct - Bloomberg Law
Google News at Macroaxis
over three weeks ago at www.macroaxis.com         
Acquisition by Rogich Sigmund of 123400 shares of Biovie at 5.04 subject to Rule 16b-3
Macroaxis News
over a month ago at www.macroaxis.com         
Acquisition by Do Cuong V of 104502 shares of Biovie at 1.9 subject to Rule 16b-3
Macroaxis News
over a month ago at news.google.com         
SEC Sues Investment Advisor Over 1.4 Million Pump-and-Dump Scheme Involving BioVie Stock - USA Heral...
Google News at Macroaxis
over a month ago at thelincolnianonline.com         
BioVie Inc. Short Interest Update
news
over two months ago at seekingalpha.com         
BioVie files to sell 7.71M shares of common stock for holders
seekingalpha News
over two months ago at gurufocus.com         
BioVie to Present Design of Planned Phase 2 Study of Bezisterim for the Treatment of Long COVID ...
Gurufocus Stories at Macroaxis
over two months ago at globenewswire.com         
BioVie to Present Design of Planned Phase 2 Study of Bezisterim for the Treatment of Long COVID at t...
Macroaxis News: globenewswire.com
over two months ago at www.macroaxis.com         
Acquisition by Berman Richard J of 51830 shares of Biovie subject to Rule 16b-3
Macroaxis News
over two months ago at finance.yahoo.com         
BioVies Upcoming Parkinsons Disease Clinical Trial is Fully Funded
Yahoo News
over two months ago at news.google.com         
BioVie Inc. Announces Closing of Registered Direct Offering BIVI Stock News - StockTitan
Google News at Macroaxis
over two months ago at globenewswire.com         
BioVie Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Macroaxis News: globenewswire.com
Far too much social signal, news, headlines, and media speculation about Biovie that are available to investors today. That information is available publicly through Biovie media outlets and privately through word of mouth or via Biovie internal channels. However, regardless of the origin, that massive amount of Biovie data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Biovie news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Biovie relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Biovie's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Biovie alpha.

Biovie Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
UPDATE -- BioVie Inc. Announces Pricing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
10/28/2024
2
BioVies Upcoming Parkinsons Disease Clinical Trial is Fully Funded
11/04/2024
3
Acquisition by Berman Richard J of 51830 shares of Biovie subject to Rule 16b-3
11/07/2024
4
BioVie to Present Design of Planned Phase 2 Study of Bezisterim for the Treatment of Long COVID at the Demystifying Long COVID International Conference
11/20/2024
5
Acquisition by Do Cuong V of 104502 shares of Biovie at 1.9 subject to Rule 16b-3
12/20/2024
6
Acquisition by Rogich Sigmund of 123400 shares of Biovie at 5.04 subject to Rule 16b-3
12/27/2024
7
BioVie Leaders Sued for Stock Slips on Clinical Trial Misconduct - Bloomberg Law
12/31/2024
8
BioVie Inc. Joins Forces With New to The Street for a Dynamic 6-Part Media Campaign Featuring Long-Form Interviews, National TV Commercials, Iconic Billboards, ...
01/13/2025

Complementary Tools for Biovie Stock analysis

When running Biovie's price analysis, check to measure Biovie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biovie is operating at the current time. Most of Biovie's value examination focuses on studying past and present price action to predict the probability of Biovie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biovie's price. Additionally, you may evaluate how the addition of Biovie to your portfolios can decrease your overall portfolio volatility.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Money Managers
Screen money managers from public funds and ETFs managed around the world
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk